VIFN.SW
Vifor Pharma AG
Price:  
166.15 
CHF
Volume:  
21,852.00
Switzerland | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VIFN.SW WACC - Weighted Average Cost of Capital

The WACC of Vifor Pharma AG (VIFN.SW) is 5.5%.

The Cost of Equity of Vifor Pharma AG (VIFN.SW) is 5.60%.
The Cost of Debt of Vifor Pharma AG (VIFN.SW) is 4.25%.

Range Selected
Cost of equity 4.40% - 6.80% 5.60%
Tax rate 9.90% - 10.80% 10.35%
Cost of debt 4.00% - 4.50% 4.25%
WACC 4.4% - 6.7% 5.5%
WACC

VIFN.SW WACC calculation

Category Low High
Long-term bond rate 1.0% 1.5%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.68 0.79
Additional risk adjustments 0.0% 0.5%
Cost of equity 4.40% 6.80%
Tax rate 9.90% 10.80%
Debt/Equity ratio 0.05 0.05
Cost of debt 4.00% 4.50%
After-tax WACC 4.4% 6.7%
Selected WACC 5.5%